Работы, на которые ссылается эта работа
Работ: 335
Работа: CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jínek, Krzysztof Chylinski, Ines Fonfara +3
Статья2012Цитирований: 7ABIMultiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong, F. Ann Ran, David Cox +8
Статья2013Цитирований: 4ABICRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Rodolphe Barrangou, Christophe Fremaux, Hélène Deveau +5
Статья2007Цитирований: 4ABIEvolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
Kira S. Makarova, Yuri I. Wolf, Jaime Iranzo +23
Обзорная статья2019Цитирований: 4ABIParkinson's disease
Bastiaan R. Bloem, Michael S. Okun, Christine Klein
Обзорная статья2021Цитирований: 4ABIIncidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Статья2003Цитирований: 3ABI53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks
Обзорная статья2014Цитирований: 3ABIRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi, Matthew H. Larson, Luke A. Gilbert +4
Статья2013Цитирований: 3ABIDelivering CRISPR: a review of the challenges and approaches
Christopher A. Lino, Jason C. Harper, James P. Carney +1
Обзорная статья2018Цитирований: 3ABIDNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu, David A. Scott, Joshua A. Weinstein +11
Статья2013Цитирований: 2ABICRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
Elitza Deltcheva, Krzysztof Chylinski, Cynthia M. Sharma +6
Статья2011Цитирований: 2ABIMeasuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9
Taeyoung Koo, Jungjoon Lee, Jin‐Soo Kim
Обзорная статья2015Цитирований: 2ABIGenome engineering using the CRISPR-Cas9 system
F. Ann Ran, Patrick D. Hsu, Jason Wright +3
Статья2013Цитирований: 2ABIEffect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga‐Morskaya +17
Статья2013Цитирований: 2ABIRNA-Guided Human Genome Engineering via Cas9
Prashant Mali, Luhan Yang, Kevin M. Esvelt +5
Статья2013Цитирований: 2ABIHigh-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu, Jennifer A Foden, Cyd Khayter +4
Статья2013Цитирований: 2ABIViral vectors: a look back and ahead on gene transfer technology.
Laura Vannucci, Michele Lai, Flavia Chiuppesi +2
Статья2013Цитирований: 2ABI